Genenta Science SpA (GNTA) Stock News
$GNTA · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Genenta Science SpA (GNTA) in the past 30 days. BORSA’s news read on GNTA is bearish at 34/100, based on 1 company event over the past 7 days.
The wire on $GNTA
newest first · updated · direct subject stories onlyGenenta Science receives Nasdaq minimum bid price deficiency notice
GNTA has 180 days to regain compliance after 30 consecutive days below $1.00. A shareholder-approved reverse split is available but not yet executed.
bearish 30 · impact 40The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
BORSAPLUSNews on Price · Earnings read · Flow and ownership · Options context
Create a free account · no card Genenta Science SpA (GNTA) stock: common questions
What is the latest Genenta Science SpA stock news?
The highest-impact GNTA story BORSA published in the past 30 days:
· Genenta Science receives Nasdaq minimum bid price deficiency noticeIs the news on GNTA bullish or bearish?
BORSA’s news read on GNTA is bearish at 34/100, based on 1 company event over the past 7 days. It measures the news only: it is separate from price action and is not investment advice.